BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12

• Press Releases

  MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference

  January 12, 2026

   · 

  9 min read
• Press Releases

  Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance

  January 12, 2026

   · 

  6 min read
• Press Releases

  Exagen Inc. Announces Select Preliminary 2025 Financial Results

  January 12, 2026

   · 

  5 min read
• Press Releases

  Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

  January 12, 2026

   · 

  3 min read
• Press Releases

  Exelixis Announces Preliminary Fiscal Year 2025 Financial Results, Provides 2026 Financial Guidance and Outlines Key Priorities and Milestones for 2026

  January 12, 2026

   · 

  19 min read
• Press Releases

  Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results

  January 12, 2026

   · 

  9 min read
• Press Releases

  Guardant Health Announces Preliminary Fourth Quarter and Full Year 2025 Results

  January 12, 2026

   · 

  5 min read
• Press Releases

  Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings - January 11, 2026

  January 12, 2026

   · 

  14 min read
• Press Releases

  Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact

  January 12, 2026

   · 

  11 min read
• Press Releases

  Natera Announces Strong Preliminary Fourth Quarter and 2025 Financial Results Driven by Record Signatera™ Growth

  January 12, 2026

   · 

  6 min read